
Nakanishi Inc
TSE:7716

Nakanishi Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
1 769
2 721
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Nakanishi Inc hold over its rivals?
What risks and challenges
does Nakanishi Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Nakanishi Inc.
Provide an overview of the primary business activities
of Nakanishi Inc.
What unique competitive advantages
does Nakanishi Inc hold over its rivals?
What risks and challenges
does Nakanishi Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Nakanishi Inc.
Provide P/S
for Nakanishi Inc.
Provide P/E
for Nakanishi Inc.
Provide P/OCF
for Nakanishi Inc.
Provide P/FCFE
for Nakanishi Inc.
Provide P/B
for Nakanishi Inc.
Provide EV/S
for Nakanishi Inc.
Provide EV/GP
for Nakanishi Inc.
Provide EV/EBITDA
for Nakanishi Inc.
Provide EV/EBIT
for Nakanishi Inc.
Provide EV/OCF
for Nakanishi Inc.
Provide EV/FCFF
for Nakanishi Inc.
Provide EV/IC
for Nakanishi Inc.
Show me price targets
for Nakanishi Inc made by professional analysts.
What are the Revenue projections
for Nakanishi Inc?
How accurate were the past Revenue estimates
for Nakanishi Inc?
What are the Net Income projections
for Nakanishi Inc?
How accurate were the past Net Income estimates
for Nakanishi Inc?
What are the EPS projections
for Nakanishi Inc?
How accurate were the past EPS estimates
for Nakanishi Inc?
What are the EBIT projections
for Nakanishi Inc?
How accurate were the past EBIT estimates
for Nakanishi Inc?
Compare the revenue forecasts
for Nakanishi Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Nakanishi Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Nakanishi Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of Nakanishi Inc compared to its peers.
Compare the P/E ratios
of Nakanishi Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing Nakanishi Inc with its peers.
Analyze the financial leverage
of Nakanishi Inc compared to its main competitors.
Show all profitability ratios
for Nakanishi Inc.
Provide ROE
for Nakanishi Inc.
Provide ROA
for Nakanishi Inc.
Provide ROIC
for Nakanishi Inc.
Provide ROCE
for Nakanishi Inc.
Provide Gross Margin
for Nakanishi Inc.
Provide Operating Margin
for Nakanishi Inc.
Provide Net Margin
for Nakanishi Inc.
Provide FCF Margin
for Nakanishi Inc.
Show all solvency ratios
for Nakanishi Inc.
Provide D/E Ratio
for Nakanishi Inc.
Provide D/A Ratio
for Nakanishi Inc.
Provide Interest Coverage Ratio
for Nakanishi Inc.
Provide Altman Z-Score Ratio
for Nakanishi Inc.
Provide Quick Ratio
for Nakanishi Inc.
Provide Current Ratio
for Nakanishi Inc.
Provide Cash Ratio
for Nakanishi Inc.
What is the historical Revenue growth
over the last 5 years for Nakanishi Inc?
What is the historical Net Income growth
over the last 5 years for Nakanishi Inc?
What is the current Free Cash Flow
of Nakanishi Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for Nakanishi Inc.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
JP |
![]() |
Nakanishi Inc
TSE:7716
|
156.9B JPY | 5.9 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
232.8B USD | 22.4 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
195.1B USD | 63.6 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
154.3B USD | 35.8 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
151B USD | 26.1 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
113.3B USD | 13.6 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
52.4B EUR | 14.1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
50.5B USD | 13.2 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
45.2B USD | 24.7 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
44.2B USD | 35 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
271.3B CNY | 21.3 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
JP |
![]() |
Nakanishi Inc
TSE:7716
|
Average EV/EBITDA:
25.1
5.9
|
6%
|
1 | |
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
22.4
|
13%
|
1.7 |
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
63.6
|
24%
|
2.6 |
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
35.8
|
21%
|
1.7 |
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
26.1
|
12%
|
2.2 |
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
13.6
|
7%
|
1.9 |
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
14.1
|
14%
|
1 |
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
13.2
|
11%
|
1.2 |
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
24.7
|
12%
|
2.1 |
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
35
|
12%
|
2.9 |
|
CN |
![]() |
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
21.3
|
16%
|
1.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.